These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 6141562)

  • 21. Receptor-agonist interactions in service-theoretic perspective, effects of molecular timing on the shape of dose-response curves.
    Kühl PW; Jobmann M
    J Recept Signal Transduct Res; 2006; 26(1-2):1-34. PubMed ID: 16595337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical pharmacology: the impact of numbers on pharmacology.
    Kenakin T; Christopoulos A
    Trends Pharmacol Sci; 2011 Apr; 32(4):189-96. PubMed ID: 21397341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpretation of relative potencies, relative efficacies and apparent affinity constants of agonist drugs estimated from concentration-response curves.
    Mackay D
    J Theor Biol; 1990 Feb; 142(3):415-27. PubMed ID: 2338830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wooldridge Memorial lecture. Pharmacology and new drug discoveries--should veterinarians be interested?
    Black J
    Vet Rec; 1984 Nov; 115(18):466-70. PubMed ID: 6506443
    [No Abstract]   [Full Text] [Related]  

  • 25. The pharmacokinetic bases of biological response quantification in toxicology, pharmacology and pharmacodynamics.
    Garrett ER
    Prog Drug Res; 1977; 21():105-230. PubMed ID: 339269
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple active receptor conformation, agonist efficacy and maximum effect of the system: the conformation-based operational model of agonism.
    Roche D; Gil D; Giraldo J
    Drug Discov Today; 2013 Apr; 18(7-8):365-71. PubMed ID: 23247260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulus amplification, efficacy, and the operational model. Part I--binary complex occupancy mechanisms.
    Trzeciakowski JP
    J Theor Biol; 1999 Jun; 198(3):329-46. PubMed ID: 10366490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates?
    Leff P; Harper D
    J Theor Biol; 1989 Oct; 140(3):381-97. PubMed ID: 2515395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
    Grenczer M; Zsuga J; Majoros L; Pinter A; Kemeny-Beke A; Juhasz B; Tosaki A; Gesztelyi R
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1074-83. PubMed ID: 21076495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of protein binding on receptor occupancy: a two-compartment model.
    Peletier LA; Benson N; van der Graaf PH
    J Theor Biol; 2010 Aug; 265(4):657-71. PubMed ID: 20561976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three-state receptor model of agonist action.
    Leff P; Scaramellini C; Law C; McKechnie K
    Trends Pharmacol Sci; 1997 Oct; 18(10):355-62. PubMed ID: 9357320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mass action equation in pharmacology.
    Kenakin T
    Br J Clin Pharmacol; 2016 Jan; 81(1):41-51. PubMed ID: 26506455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method.
    Calderone V; Martinotti E
    J Pharmacol Toxicol Methods; 1998 Jul; 40(1):57-62. PubMed ID: 9920535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of assay formats on the estimation of melanocortin agonist affinity and efficacy using the operation model of agonism.
    Simon S; Young TJ; Nickolls SA
    Eur J Pharmacol; 2009 Aug; 615(1-3):33-9. PubMed ID: 19446549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Individualized drug therapy].
    Aarbakke J
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2794-5. PubMed ID: 11107927
    [No Abstract]   [Full Text] [Related]  

  • 38. Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex models.
    Mackay D
    Trends Pharmacol Sci; 1990 Jan; 11(1):17-22. PubMed ID: 2408209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the operational model when applied to quantify functional selectivity.
    Zhu X; Finlay DB; Glass M; Duffull SB
    Br J Pharmacol; 2018 May; 175(10):1654-1668. PubMed ID: 29457969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic ligand-receptor interaction model: operational model of agonism.
    Kim H; Lim HS
    Transl Clin Pharmacol; 2018 Sep; 26(3):115-117. PubMed ID: 32055560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.